2019 / 05

Следующая статья
DOI: 10.24075/vrgmu.2019.065

ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ

Протромбогенные полиморфные варианты генов системы гемостаза и фолатного обмена при асептическом тромбозе церебральных венозных синусов

М. Ю. Максимова, Ю. И. Дубовицкая, М. В. Кротенкова, А. А. Шабалина
Информация об авторах

Научный центр неврологии, Москва, Россия

Для корреспонденции: Марина Юрьевна Максимова
Волоколамское шоссе, д. 80, г. Москва, 125367; ur.liam@avomixamncn

Информация о статье

Финансирование: работа выполнена в рамках государственного задания ФГБНУ НЦН.

Вклад авторов в работу: М. Ю. Максимова — разработка концепции и организация исследования, обобщающий анализ клинических и лабораторных данных, статистическая обработка, написание статьи; Ю. И. Дубовицкая — проведение клинического обследования пациентов, сбор и первичный анализ полученных результатов; М. В. Кротенкова — проведение МРТ головного мозга, МР-веносинусографии и нейровизуализационной диагностики тромбоза церебральных венозных синусов; А. А. Шабалина — проведение лабораторного исследования протромбогенных полиморфных вариантов генов гемостаза и фолатного обмена.

Статья получена: 19.08.2019 Статья принята к печати: 06.10.2019 Опубликовано online: 16.10.2019
|
  1. Behrouzi R, Punter M. Diagnosis and management of cerebral venous thrombosis. Clin Med (Lond). 2018; 18 (1): 75–9. DOI: 10.7861/clinmedicine.18-1-75.
  2. Maali L, Khan S, Qeadan F, Ismail M, Ramaswamy D, Hedna VS. Cerebral venous thrombosis: continental disparities. Neurol Sci. 2017; 38 (11): 1963–8. PubMed PMID: 28808795. DOI: 10.1007/ s10072-017-3082-7.
  3. Lee DJ, Ahmadpour A, Binyamin T, Dahlin BC, Shahlaie K, Waldau B. Management and outcome of spontaneous cerebral venous sinus thrombosis in a 5-year consecutive single-institution cohort. J Neurointerv Surg. 2017; 9 (1): 34–8. DOI: 10.1136/ neurintsurg-2015-012237.
  4. Agrawal K, Burger K, Rothrock JF. Cerebral sinus thrombosis. Headache. 2016; 56 (8): 1380–9. DOI: 10.1111/head.12873.
  5. Capecchi M, Abbattista M, Martinelli I. Cerebral venous sinus thrombosis. J Thromb Haemost. 2018;16 (10):1918–31. DOI: 10.1111/jth.14210.
  6. Coutinho JM, Zuurbier SM, Aramideh M, Stam J. The incidence of cerebral venous thrombosis: a cross-sectional study. Stroke. 2012; 43 (12): 3375–7. PubMed PMID: 22996960. DOI: 10.1161/ STROKEAHA.112.671453.
  7. Janghorbani M, Zare M, Saadatnia M, Mousavi SA, Mojarrad M, Asgari E. Cerebral vein and dural sinus thrombosis in adults in Isfahan, Iran: frequency and seasonal variation. Acta Neurol Scand. 2008; 117 (2): 117–21. PubMed PMID: 18184347. DOI: 10.1111/j.1600-0404.2007.00915.x.
  8. Coutinho JM, Zuurbier SM, Stam J. Declining mortality in cerebral venous thrombosis: a systematic review. Stroke. 2014; 45 (5): 1338–41. DOI: 10.1161/STROKEAHA.113.004666.
  9. de Freitas GR, Bogousslavsky J. Risk factors of cerebral vein and sinus thrombosis. Front Neurol Neurosci. 2008; (23): 23–54.
  10. Kashkoush AI, Ma H, Agarwal N, Panczykowski D, Tonetti D, Weiner GM, et al. Cerebral venous sinus thrombosis in pregnancy and puerperium: A pooled, systematic review. J Clin Neurosci. 2017; (39): 9–15. DOI: 10.1016/j.jocn.2017.02.046.
  11. Bushnell C, McCullough LD, Awad IA, Chireau MV, Fedder WN, Furie KL, et al. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014; 45 (5): 1545–88. DOI: 10.1161/01.str.0000442009.06663.48.
  12. Ilyas A, Chen CJ, Raper DM, Ding D, Buell T, Mastorakos P, et al. Endovascular mechanical thrombectomy for cerebral venous sinus thrombosis: a systematic review. J Neurointerv Surg. 2017; 9 (11):1086–92. DOI: 10.1136/neurintsurg-2016-012938.
  13. McBane RD, Tafur A, Wysokinski WE. Acquired and congenital risk factors associated with cerebral venous sinus thrombosis. Thromb Res. 2010; 126 (2): 81–7. DOI: 10.1016/j.thromres.2010.04.015.
  14. Martinelli I, Cattaneo M, Taioli E, De Stefano V, Chiusolo P, Mannucci PM. Genetic risk factors for superficial vein thrombosis. Thromb Haemost. 1999; 82 (4): 1215–7. PMID: 10544900.
  15. Bushnell C, Saposnik G. Evaluation and management of cerebral venous thrombosis. Continuum (Minneap Minn). 2014; 20 (2 Cerebrovascular Disease): 335–51. DOI: 10.1212/01. CON.0000446105.67173.a8.
  16. Marjot T, Yadav S, Hasan N, Bentley P, Sharma P. Genes associated with adult cerebral venous thrombosis. Stroke. 2011; 42 (4): 913–8. DOI: 10.1161/STROKEAHA.110.602672.
  17. Ferro JM, Bousser MG, Canhão P, Coutinho JM, Crassard I, Dentali F, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis — Endorsed by the European Academy of Neurology. Eur Stroke J. 2017; 2 (3): 195–221. DOI: 10.1177/2396987317719364.
  18. Alshoabi SA. Cerebral venous sinus thrombosis: a diagnostic challenge in a rare presentation. Brain Circ. 2017; 3 (4): 227–230. DOI: 10.4103/bc.bc_27_17.
  19. Gao L, Xu W, Li T, Yu X, Cao S, Xu H, et al. Accuracy of magnetic resonance venography in diagnosing cerebral venous sinus thrombosis. Thromb Res. 2018; (167): 64–73. DOI: 10.1016/j. thromres.2018.05.012.
  20. Goyal G, Charan A, Singh R. Clinical Presentation, Neuroimaging Findings, and Predictors of Brain Parenchymal Lesions in Cerebral Vein and Dural Sinus Thrombosis: A Retrospective Study. Ann Indian Acad Neurol. 2018; 21 (3): 203–8. DOI: 10.4103/aian. AIAN_470_17.
  21. Cai H, Ye X, Zheng W, Ma L, Hu X, Jin X. Pitfalls in the diagnosis and initial management of acute cerebral venous thrombosis. Rev Cardiovasc Med. 2018; 19 (4): 129–33. DOI: 10.31083/j. rcm.2018.04.4081.
  22. Ferro JM, Canhão P, Aguiar de Sousa D. Cerebral Venous Thrombosis. Presse Med. 2016; 45 (12 Pt 2): e429–e450. PubMed PMID: 27816347. DOI: 10.1016/j.lpm.2016.10.007.
  23. Schneider S, Kapelushnik J, Kraus M, El Saied S, Levi I, Kaplan DM. The association between otogenic lateral sinus thrombosis and thrombophilia — A long-term follow-up. Am J Otolaryngol. 2018; 39 (3): 299–302. PubMed PMID: 29530427. DOI: 10.1016/j. amjoto.2018.03.013.
  24. Lichy C, Dong–Si T, Reuner K, Genius J, Rickmann H, Hampe T, et al. Risk of cerebral venous thrombosis and novel gene polymorphisms of the coagulation and fibrinolytic systems. J Neurol. 2006; 253 (3): 316–20. PubMed PMID: 16155788. DOI: 10.1007/s00415-005-0988-4.
  25. Li B, Heldner MR, Arnold M, Coutinho JM, Zuurbier SM, Meijers JCM, et al. Coagulation Factor XIII in Cerebral Venous Thrombosis. TH Open. 2019; 3 (3): e227–e229. DOI: 10.1055/s- 0039-1693487.
  26. Bagoly Z, Muszbek L. Factor XIII: What does it look like? J Thromb Haemost. 2019; 17 (5): 714–6. DOI: 10.1111/jth.14431.
  27. Ali Z, Troncoso JC, Fowler DR. Recurrent cerebral venous thrombosis associated with heterozygote methylenetetrahydrofolate reductase C677T mutation and sickle cell trait without homocysteinemia: an autopsy case report and review of literature. Forensic Sci Int. 2014; (242): e52–e55. DOI: 10.1016/j.forsciint.2014.07.007.
  28. Ghaznavi H, Soheili Z, Samiei S, Soltanpour MS. Association study of methylenetetrahydrofolate reductase C677T mutation with cerebral venous thrombosis in an Iranian population. Blood Coagul Fibrinolysis. 2015; 26 (8): 869–73. DOI: 10.1097/ MBC.0000000000000292.